Shanghai Pharmaceutical Co., Ltd. provides earnings guidance for the first quarter of 2012. For the quarter, the company expects that the net profit attributable to equity holders of the company to decrease by approximately 40% as compared to the same period of last year. As disclosed in the 2011 first quarterly report of the company published on the Shanghai Stock Exchange, the net profit attributable to equity holders of the company for the first quarter of 2011 was RMB 848,593,633.2 and the basic earnings per share for the same period was RMB 0.4259. The reason for the decrease in the net profit attributable to equity holders of the company for the first quarter of 2012 is that, in the first quarter of 2011, a high one-off gain on investment was recorded due to the fact that Techpool Bio-Pharma Co., Ltd. was no longer included in the consolidated financial statements of the Group, while there was no such gain on investment due to changes in the accounting treatment in the first quarter of 2012.